Viewing Study NCT00672295


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-03 @ 10:47 AM
Study NCT ID: NCT00672295
Status: COMPLETED
Last Update Posted: 2012-12-28
First Post: 2008-05-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Sponsor: AA Secord
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module